A Wonderful Epic Experience!

Hi Guys,

You can read all my posts at the blog site by clicking here .  Last week I attended a week long cancer camp called “Epic Experience” at Sweetwater, Colorado.  So much fun and recreation was had by all.   Nancy Ferro and her son Colin offered us horseback riding, kayaking, rafting, swimming, fun games and much more activities for the week in a breath taking scene high up in the Colorado mountains. 

The menu for the week was building our Confidence and growing our Hope!  I am sure all of us went away with much more personal confidence and hope to fight our cancer.  We kayaked 45 miles of the Colorado river and challenged ourselves to set our goals high with renewed hope.  You can contact Nancy, (www.epicexperience.org) if you want to participate in such a moving and fun experience.  Dealing with our cancer is a hard thing to do.  People like Nancy, Colin and all of their volunteers made a difference in our lives while teaching us we can make it through our cancer and beat this disease.  Our new found hope inspired us to “MAKE EVERY DAY COUNT”!   (Personally I think God made people like the Epic Experience group as our angels on earth)!

Cancer is or Tragedy, not our Destiny!

Craig Becker

The New Denver Men’s Club

Blog: https://newdenvermensclub.wordpress.com/

“Men Fighting Cancer To Win”

 
Advertisements

New Nanoparticle Created for Cancer Therapy + ‘eNose’ Sniffs Out Prostate Cancer Shows Promise

 

Hi Guys,

Article #1, Wei Chen, professor of physics and co-director of UT Arlington’s Center for Security Advances Via Applied Nanotechnology, was working to create a luminescent nanoparticle to use in radiation detection may have instead happened upon an advance in photodynamic cancer therapy.  Article #2 states that new research from Finland suggests in the not-too-distant future we may be making rapid, early diagnoses of prostate cancer using a noninvasive electronic nose that sniffs a urine sample. 

1)   New Nanoparticle Created for Cancer Therapy  (20 April 2014 – 12am)

“Because Chen also is leading federally funded cancer research, he knew he had found something unique. Testing revealed that the Cu-Cy nanoparticles, combined with X-ray exposure, significantly slowed tumor growth in lab studies”.

 

Cell ComparisonThis figure from the paper shows the X-ray destruction of human breast cancer cells using Cu-Cy particles. The images show the live cancer cells stained green and the dead cells stained red!   Full Story:  New Nanoparticle Created for Cancer Therapy

2)   ‘eNose’ Sniffs Out Prostate Cancer Shows Promise   (2 May 2014 – 8am)

“In a report of their proof of principle study in the Journal of Urology, researchers from the University of Tampere describe how the “eNose” successfully differentiated between prostate cancer and benign prostatic hyperplasia (BPH) by analyzing the “smell print” of the headspace of a urine sample (the air immediately above the urine)”.  The team says the results from the eNose are comparable to those obtained from prostate specific antigen (PSA) tests!   Full Story:  ‘eNose’ that sniffs out prostate cancer shows promise

“When tears happen: Endure, grieve, and move on. The only person who is with us our entire life is ourselves. LIVE large while you are alive”.

Craig Becker

The New Denver Men’s Club

Blog: https://newdenvermensclub.wordpress.com/   “Men Fighting Cancer To Win”

Breakthrough Cancer Treatment Has Potential To Kill All Types Of Tumors!

 

 

Hi Guys,

Article #1 is a promising  new breakthrough from Irving Weissman and his team at Stanford that have developed a treatment capable of killing cancer cells while leaving healthy cells largely unharmed.  The new treatment acts on the protein CD47, a protein found on the surface of cancer cells that essentially says “don’t eat me” to a person’s immune system. CD47 tricks the immune system of someone with cancer into letting tumors continue to grow.  This is just opening up clinical trial 1 for patients!  Article #2 from the Mayo Clinic deals with Genome guided therapeutic trials for cancer.

1)   Breakthrough Cancer Treatment Has Potential To Kill All Types Of Tumors      March 31, 2014

“The groundbreaking therapy has proven incredibly effective in animal testing so far. To test the treatment on human cancers, researchers implanted human cancer tumors in to mice. In the absence of treatment, these tumors would continue to grow in the mice. But this all changed when the CD47 antibody was used.  The new cell therapy cured or shrunk human strands of breast, ovary, colon, bladder, brain, liver, and prostate tumors during trials”.  Full Story: Breakthrough Cancer Treatment Has Potential To Kill All Types Of Tumors

2)   Genome-guided therapeutic trials offer new hope   Vol. 3, Issue 1, 2014

“With the availability of more comprehensive human genome data from sources such as The Cancer Genome Atlas, clinicians are now able to rapidly and inexpensively sequence an individual patient’s tumors. The result is new opportunities for researchers to conduct therapeutic trials for many types of cancer.  The Mayo Clinic Cancer Center took its first steps in this direction nearly two years ago when we launched our first genome-guided protocol in a neoadjuvant trial for newly diagnosed breast cancer patients.  We have just launched a similar approach for prostate cancer, and we plan to extend this approach to other malignancies”.  Full Story:  Genome-guided therapeutic trials offer new hope.

 

It seems to me that the future defeating prostate cancer and many other cancers will depend on how well we develop Immuno, Genome, targeted, Individualizing cancer treatment and vaccine therapy’s! 

Craig Becker

The New Denver Men’s Club

Blog: https://newdenvermensclub.wordpress.com/

“Men Fighting Cancer To Win”

 

“ZL105 drug could potentially replace currently used anticancer drugs”!

Hi Guys,

A new study at the University of Warwick, published today in the journal Angewandte Chemie International Edition, claims a revolution in cancer treatment could soon be underway following a breakthrough that may lead to a dramatic improvement in cancer survival rates.

1)   ZL105 drug could potentially replace currently used anticancer drugs, study finds  Posted:March 26, 2014 

“Called ZL105, the drug is a compound based on the precious metal iridium. The study has found ZL105 could potentially replace currently used anticancer drugs, which become less effective over time, cause a wide-range of side-effects and damage healthy cells as well as cancerous.  Commenting on the breakthrough, University of Warwick researcher and study co-author Dr Isolda Romero-Canelon said The energy-producing machinery in cancer cells works to the limit as it attempts to keep up with quick proliferation and invasion. This makes cancer cells susceptible to minor changes in the cell ‘power-house’. Our drug pushes cancer cells over the limit causing them to slow and shut down, whilst normal cells can cope with its effects”.     Full Story: ZL105 drug could potentially replace currently used anticancer drugs!

Johns Hopkins Health Alert, Posted in Prostate Disorders on March 26, 2014                                                                                                                                                                                                                     2)   Promising Treatment for Metastatic Prostate Cancer                                                                                                                                                                                                                                            

“Early results from an ongoing National Institutes of Health-funded clinical trial look promising for men who have metastatic prostate cancer — the kind that spreads to major organs such as the liver or lungs or to the bones or adrenal glands.  The study, which was reported in a National Institutes of Health press release, is examining the effectiveness of combining chemotherapy with hormone therapy for advanced prostate cancer, and so far, the combination has extended three-year survival rates from 52.5 percent to 69 percent.  Men with hormone-sensitive metastatic prostate cancer are typically treated first with androgen deprivation therapy (ADT), a hormone treatment that blocks or limits the production of male hormones, which results in reduced or slower-growing tumors. After researchers added the chemotherapy drug docetaxel at the start of the hormone therapy regimen, they noted significant improvement in survival among patients with the most advanced prostate cancer”.

The early study results were made public because both Food and Drug Administration (FDA)-approved drugs are available to be put to immediate use in patients with a high extent of metastatic prostate cancer. Researchers continue to study the combination therapy to determine its effectiveness in treating less extensive metastatic prostate cancer.  Full Story: Promising Treatment for Metastatic Prostate Cancer

“We need to be reminded that life is here to enjoy but the opportunity to do so does not last forever”.

Craig Becker

The New Denver Men’s Club

Blog: https://newdenvermensclub.wordpress.com/

“Men Fighting Cancer To Win”